[Therapy of psoriasis with dehydroepiandrosterone-enanthate. II. Intramuscular depot application of 300 mg weekly (author's transl)].
D000737:Androstenols / Q000097:blood; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*
D000737:Androstenols; D003692:Delayed-Action Preparations; D003687:Dehydroepiandrosterone; D005954:Glucosephosphate Dehydrogenase
Zur Therapie der Psoriasis mit Dehydroepiandrosteron-Oenanthat. II. I.m. Verabfolgung von 300 mg Depot pro Woche.